Presentation Agenda

• Background

• 2 Pivotal Phase III Controlled Clinical Trials

  • Improved Tumor Control
  • Improved Survival

• Summary and Conclusions

• Q&A

Previous slide

Next slide

Back to first slide

View graphic version